Related Experiment Videos
Malignant neoplasms following bone marrow transplantation
S Bhatia1, N K Ramsay, M Steinbuch
1Department of Pediatrics, University of Minnesota Medical School, Minneapolis, USA.
Blood
|May 1, 1996
Summary
Bone marrow transplant (BMT) recipients face a significantly higher risk of developing post-transplant cancers, including B-cell lymphoproliferative disorders and solid tumors. Increased surveillance is crucial for managing this elevated cancer risk in BMT survivors.
Area of Science:
- Oncology
- Hematology
- Transplantation Medicine
Background:
- Bone marrow transplantation (BMT) is a life-saving procedure for various hematologic and oncologic conditions.
- Long-term survivors of BMT may face unique health challenges, including an increased risk of secondary malignancies.
- Understanding the incidence and risk factors for post-BMT cancers is critical for improving patient outcomes.
Purpose of the Study:
- To determine the incidence of malignant neoplasms (MNs) after bone marrow transplant (BMT).
- To identify specific types of cancers that occur more frequently in BMT recipients.
- To investigate factors associated with an increased risk of developing post-BMT malignancies.
Main Methods:
- Analysis of 2,150 BMT recipients at the University of Minnesota.
- Comparison of observed cancer incidence with general population rates using standardized incidence ratios (SIRs).
- Actuarial analysis to estimate the cumulative probability of developing specific malignancies over time.
Main Results:
- BMT recipients showed a significantly higher incidence of MNs (SIR = 11.6) compared to the general population.
- The most common post-BMT malignancies included B-cell lymphoproliferative disorder (BLPD), solid nonhematopoietic tumors, and myelodysplastic syndromes (MDS)/acute myelogenous leukemia (AML).
- Independent risk factors for increased malignancy risk included T-cell depletion, HLA mismatch, antithymocyte globulin (ATG) use, and primary immunodeficiency.
Conclusions:
- BMT recipients are at a substantially increased risk for developing secondary malignancies, contributing to morbidity and mortality.
- Specific risk factors highlight the need for tailored surveillance strategies.
- Further research is required to develop effective screening and identification methods for at-risk individuals.